Joseph Schlessinger's most recent trade in Inozyme Pharma Inc was a trade of 100,000 Series A Convertible Preferred Stock done . Disclosure was reported to the exchange on July 28, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Inozyme Pharma Inc | Joseph Schlessinger | Ten Percent Owner | 28 Jul 2020 | 100,000 | 0 | - | - | Series A Convertible Preferred Stock | ||
Inozyme Pharma Inc | Joseph Schlessinger | Ten Percent Owner | 28 Jul 2020 | 13,381 | 286,479 | - | - | Common Stock |